Cargando…

Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model

This protocol uses the Tg4 Nr4a3-Tocky mouse model to recalibrate T cell activation thresholds and reveals the role that immune checkpoints play in controlling T cell activation. The example approach here uses flow cytometry to characterize quantitative and qualitative changes in splenic CD4(+) T ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheriff, Lozan, Bending, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829797/
https://www.ncbi.nlm.nih.gov/pubmed/35169717
http://dx.doi.org/10.1016/j.xpro.2022.101161
_version_ 1784648144658628608
author Sheriff, Lozan
Bending, David
author_facet Sheriff, Lozan
Bending, David
author_sort Sheriff, Lozan
collection PubMed
description This protocol uses the Tg4 Nr4a3-Tocky mouse model to recalibrate T cell activation thresholds and reveals the role that immune checkpoints play in controlling T cell activation. The example approach here uses flow cytometry to characterize quantitative and qualitative changes in splenic CD4(+) T cells reactivated in the presence of anti-PD1 immunotherapy. The protocol is optimized for studying anti-PD1 pathway blockade only. The protocol is not compatible with cellular fixation, and T cells should be analyzed immediately after staining. For complete details on the use and execution of this protocol, please refer to Elliot et al. (2021).
format Online
Article
Text
id pubmed-8829797
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88297972022-02-14 Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model Sheriff, Lozan Bending, David STAR Protoc Protocol This protocol uses the Tg4 Nr4a3-Tocky mouse model to recalibrate T cell activation thresholds and reveals the role that immune checkpoints play in controlling T cell activation. The example approach here uses flow cytometry to characterize quantitative and qualitative changes in splenic CD4(+) T cells reactivated in the presence of anti-PD1 immunotherapy. The protocol is optimized for studying anti-PD1 pathway blockade only. The protocol is not compatible with cellular fixation, and T cells should be analyzed immediately after staining. For complete details on the use and execution of this protocol, please refer to Elliot et al. (2021). Elsevier 2022-02-03 /pmc/articles/PMC8829797/ /pubmed/35169717 http://dx.doi.org/10.1016/j.xpro.2022.101161 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Protocol
Sheriff, Lozan
Bending, David
Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model
title Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model
title_full Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model
title_fullStr Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model
title_full_unstemmed Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model
title_short Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model
title_sort flow cytometric analysis of cd4+ t cell reactivation following anti-pd1 immunotherapy in a transgenic mouse model
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829797/
https://www.ncbi.nlm.nih.gov/pubmed/35169717
http://dx.doi.org/10.1016/j.xpro.2022.101161
work_keys_str_mv AT sherifflozan flowcytometricanalysisofcd4tcellreactivationfollowingantipd1immunotherapyinatransgenicmousemodel
AT bendingdavid flowcytometricanalysisofcd4tcellreactivationfollowingantipd1immunotherapyinatransgenicmousemodel